Secondary Blood Grouping and Sickle Testing
- NHS Blood and Transplant
Procurement identifier (OCID): ocds-h6vhtk-040cd2
Description
NHSBT is looking to award a Managed Service Contract for the supply of commercially available automated blood group testing equipment for use as a secondary testing technology for ABO and Rh D typing, antibody screening and identification, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood, tissues and stem cell (haemopoietic progenitor cells and therapeutic cells) samples.
Notices
F03: Contract award notice
- Notice identifier
- 2025/S 000-043037
- Published
- 25 July 2025, 10:40am
F02: Contract notice
- Notice identifier
- 2024/S 000-014870
- Published
- 9 May 2024, 4:27pm
F01: Prior information notice
- Notice identifier
- 2023/S 000-030665
- Published
- 17 October 2023, 5:03pm